235 related articles for article (PubMed ID: 35590366)
1. A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease.
Hu X; Fan J; Ma Q; Han L; Cao Z; Xu C; Luan J; Jing G; Nan Y; Wu T; Zhang Y; Wang H; Zhang Y; Ju D
J Nanobiotechnology; 2022 May; 20(1):237. PubMed ID: 35590366
[TBL] [Abstract][Full Text] [Related]
2. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.
Barchetta I; Cimini FA; Chiappetta C; Bertoccini L; Ceccarelli V; Capoccia D; Gaggini M; Di Cristofano C; Della Rocca C; Silecchia G; Leonetti F; Lenzi A; Gastaldelli A; Cavallo MG
Liver Int; 2020 Sep; 40(9):2139-2147. PubMed ID: 32510837
[TBL] [Abstract][Full Text] [Related]
3. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
4. Physiological roles and regulation of hepatic angiopoietin-like protein 3 in Japanese Black cattle (Bos taurus) during the fattening period.
Shikida R; Kim M; Futohashi M; Nishihara K; Lee H; Suzuki Y; Baek Y; Masaki T; Ikuta K; Iwamoto E; Uemoto Y; Haga S; Terada F; Roh S
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37317898
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.
Burks KH; Basu D; Goldberg IJ; Stitziel NO
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101688. PubMed ID: 35999139
[TBL] [Abstract][Full Text] [Related]
6. Evinacumab to treat hypercholesterolemia.
Engler C; Ebenbichler C
Drugs Today (Barc); 2021 Oct; 57(10):607-619. PubMed ID: 34713869
[TBL] [Abstract][Full Text] [Related]
7. A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice.
Zhang P; Wang K; Hu T; Xu M; You X; Chen M; Tang X; Hu H; Jiang Y; Zhao W; Tan S
FASEB J; 2024 Jan; 38(1):e23399. PubMed ID: 38174870
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance.
Adam RC; Mintah IJ; Alexa-Braun CA; Shihanian LM; Lee JS; Banerjee P; Hamon SC; Kim HI; Cohen JC; Hobbs HH; Van Hout C; Gromada J; Murphy AJ; Yancopoulos GD; Sleeman MW; Gusarova V
J Lipid Res; 2020 Sep; 61(9):1271-1286. PubMed ID: 32646941
[TBL] [Abstract][Full Text] [Related]
9. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
[TBL] [Abstract][Full Text] [Related]
10. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ
J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
[TBL] [Abstract][Full Text] [Related]
11. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
[TBL] [Abstract][Full Text] [Related]
13. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits.
Hoffmann WG; Chen YQ; Schwartz CS; Barber JL; Dev PK; Reasons RJ; Miranda Maravi JS; Armstrong B; Gerszten RE; Silbernagel G; Konrad RJ; Bouchard C; Sarzynski MA
J Lipid Res; 2024 Feb; 65(2):100495. PubMed ID: 38160757
[TBL] [Abstract][Full Text] [Related]
14. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism.
Burks KH; Xie Y; Gildea M; Jung IH; Mukherjee S; Lee P; Pudupakkam U; Wagoner R; Patel V; Santana K; Alisio A; Goldberg IJ; Finck BN; Fisher EA; Davidson NO; Stitziel NO
J Lipid Res; 2024 Feb; 65(2):100500. PubMed ID: 38219820
[TBL] [Abstract][Full Text] [Related]
16. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
Mohamed F; Mansfield BS; Raal FJ
Curr Atheroscler Rep; 2022 Dec; 24(12):959-967. PubMed ID: 36367663
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia.
Surma S; RomaĆczyk M; Filipiak KJ
Cardiol J; 2023; 30(1):131-142. PubMed ID: 33470417
[TBL] [Abstract][Full Text] [Related]
18. New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.
Su X; Peng DQ
Lipids Health Dis; 2018 Jan; 17(1):12. PubMed ID: 29334984
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Xiao HB; Wang JY; Sun ZL
Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
[TBL] [Abstract][Full Text] [Related]
20. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.
Sylvers-Davie KL; Davies BSJ
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E493-E508. PubMed ID: 34338039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]